Skip to Content

Aethlon Medical Inc AEMD

Morningstar Rating
$1.68 −0.03 (1.75%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AEMD is trading at a 65% discount.
Price
$1.75
Fair Value
$6.15
Uncertainty
Extreme
1-Star Price
$88.36
5-Star Price
$6.35
Economic Moat
Mtw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AEMD is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.71
Day Range
$1.671.74
52-Week Range
$1.407.20
Bid/Ask
$1.68 / $1.74
Market Cap
$4.40 Mil
Volume/Avg
14,918 / 10,568

Key Statistics

Price/Earnings (Normalized)
Price/Sales
7.11
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Aethlon Medical Inc is a medical technology company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
15

Valuation

Metric
AEMD
Price/Earnings (Normalized)
Price/Book Value
0.57
Price/Sales
7.11
Price/Cash Flow
Price/Earnings
AEMD

Financial Strength

Metric
AEMD
Quick Ratio
3.80
Current Ratio
3.93
Interest Coverage
Quick Ratio
AEMD

Profitability

Metric
AEMD
Return on Assets (Normalized)
−70.56%
Return on Equity (Normalized)
−86.06%
Return on Invested Capital (Normalized)
−81.68%
Return on Assets
AEMD
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesMtfdtwzlSndmbwb$197.2 Bil
SYK
Stryker CorpPqdwrppcjRsvp$136.2 Bil
MDT
Medtronic PLCKxtdnklpMmqrxw$115.7 Bil
BSX
Boston Scientific CorpYdlskftzbNnsqkq$100.7 Bil
EW
Edwards Lifesciences CorpTyyhhfnrKzclrd$57.5 Bil
DXCM
DexCom IncXwbwpdbvZtrgq$53.5 Bil
ZBH
Zimmer Biomet Holdings IncPhlmwpnmmYxm$27.1 Bil
ALGN
Align Technology IncKhfclsbvVxrqx$24.6 Bil
PODD
Insulet CorpDjbkplkyHzldvy$12.0 Bil
LIVN
LivaNova PLCJmczsJttzw$3.0 Bil

Sponsor Center